• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bio-Rad Laboratories (NY: BIO )

    358.19 +27.61 (+8.35%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Bio-Rad Laboratories

    < Previous 1 2 3 4 5 6 Next >
    Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Stocks Roar Back To Life; Still Pacing For Weekly Loss
    Rebounding bank stocks, stellar Apple earnings, and a blowout jobs report are all helping stocks move significantly higher Friday afternoon. 
    Via Talk Markets
    Recap: Bio-Rad Laboratories Q1 Earnings
    Via Benzinga
    Bio-Rad Reports First-Quarter 2023 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Golden Cross Appears Before Bio-Rad Laboratories Investors
    Via Benzinga
    Earnings Scheduled For February 16, 2023
    Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
    Via Benzinga
    Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers 
    Via Benzinga
    The 3 Most Promising Biotech Stocks to Buy Now
    With the NIH requesting its biggest budget yet, these are the three most promising healthcare stocks to buy now. 
    Via InvestorPlace
    Earnings Outlook For Bio-Rad Laboratories
    Via Benzinga
    I Asked ChatGPT for 10 EV Stocks to Buy. Here’s What It Recommended.
    What are the best EV stocks to buy? ChatGPT has different answers, depending on how it is asked. Here's what investors need to know. 
    Via InvestorPlace
    Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
    New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems 
    From Cytek Biosciences, Inc.
    Via GlobeNewswire
    Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
    Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
    Via Investor's Business Daily
    Thoughts For Thursday: All Eyes On The CPI
    All eyes are on the release of the December Consumer Price Index data later today. 2023 has started as a relatively up year for equities and a continued downward trajectory seems necessary to keep the... 
    Via Talk Markets
    Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says
    Via Benzinga
    Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad Reports Third-Quarter 2022 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Friday
      During Friday, 125 stocks hit new 52-week lows. 
    Via Benzinga
    Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
    One analyst doubts any deal could come to fruition. If it did, it would make sense. 
    Via Investor's Business Daily
    Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11
    Reuters US-China Chip War: KLA Relaxes Chip Supply To China 
    Via Benzinga
    Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
    Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all. 
    Via Benzinga
    Bio-Rad Acquires Curiosity Diagnostics
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
    Upgrades 
    Via Benzinga
    Bio-Rad Laboratories: Q2 Earnings Insights
    Bio-Rad Laboratories (NYSE:BIO) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Bio-Rad Reports Second-Quarter 2022 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.